Dosage and administration
Take one tablet daily or as prescribed by a physician.
Take one tablet daily or as prescribed by a physician.
Vol-Plus is a prescription vitamin for the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation, including women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
General: Folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive.
The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
Pyridoxine hydrochloride should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine hydrochloride. However, pyridoxine hydrochloride may be used concurrently in patients receiving a preparation containing both carbidopa and levodopa. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
Allergic sensitization has been reported following both oral and parenteral administration of folic acid, as well as possibly the use of other forms of folates - including reduced folates.
Paresthesia, somnolence, nausea and headaches have been reported with pyridoxine hydrochloride.
Mild transient diarrhea, polycythemia vera, itching, transitory exanthema and the feeling of swelling of the entire body have been associated with cyanocobalamin.
Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and subside with continuation of therapy and physician encouragement. Although, the absorption of iron is best when taken between meals, occasional gastrointestinal disturbances may be controlled giving Vol-Plus shortly after meals.
Vol-Plus is an oval, beige tablet imprinted with “TL519”.
Take one tablet daily or as prescribed by a physician.
Vol-Plus is supplied in bottles of 100 tablets and bottles of 500 tablets.
Product Code: 13811-519-10 (Bottles of 100 tablets)
Product Code: 13811-519-50 (Bottles of 500 tablets)
Store at room temperature 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F) [see USP controlled room temperature]. Dispense in a tight, light resistant container as defined by the USP with a child resistant closure. Protect from light and moisture and avoid excessive heat. Note that contact with moisture may produce surface discoloration of the tablet.
KEEP OUT OF REACH OF CHILDREN.
For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, call Trigen Laboratories, LLC at 1-888-9-TRIGEN (1-888-987-4436) or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.
Rev. 07/2018
Customer Service: 1-888-987-4436
Manufactured for:
Trigen Laboratories, LLC
Bridgewater, NJ 08807
www.trigenlab.com
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13811-519-01 | EA - Each | 13811-519 | 5a2be96c-067d-4b1f-a809-43f74bdefabb | 1 | 2014-12-01 |
| 13811-519-10 | EA - Each | 13811-519 | 3461cce0-f434-4a24-92b7-d9ba7c8c5c16 | 1 | 2013-06-04 |
| 13811-519-50 | EA - Each | 13811-519 | 6e85543e-ceb7-470d-9f25-51fe3a054a87 | 1 | 2013-06-04 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .alpha.-tocopherol acetate, dl- | ACTIVE INGREDIENT | WR1WPI7EW8 | 3 | |
| .beta.-carotene | ACTIVE INGREDIENT | 01YAE03M7J | 3 | |
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 3 | |
| calcium sulfate | ACTIVE INGREDIENT | WAT0DDB505 | 3 | |
| cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 3 | |
| cupric oxide | ACTIVE INGREDIENT | V1XJQ704R4 | 3 | |
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 3 | |
| ferrous fumarate | ACTIVE INGREDIENT | R5L488RY0Q | 3 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 3 | |
| niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 3 | |
| pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 3 | |
| riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 3 | |
| thiamine mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 3 | |
| vitamin A acetate | ACTIVE INGREDIENT | 3LE3D9D6OY | 3 | |
| zinc oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 3 | |
| .ALPHA.-TOCOPHEROL, DL- | ACTIVE MOIETY | 7QWA1RIO01 | 3 | |
| .beta.-carotene | ACTIVE MOIETY | 01YAE03M7J | 3 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 3 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 3 | |
| cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 3 | |
| CUPRIC CATION | ACTIVE MOIETY | 8CBV67279L | 3 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 3 | |
| FERROUS CATION | ACTIVE MOIETY | GW89581OWR | 3 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 3 | |
| niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 3 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 3 | |
| riboflavin | ACTIVE MOIETY | TLM2976OFR | 3 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 3 | |
| VITAMIN A | ACTIVE MOIETY | 81G40H8B0T | 3 | |
| zinc oxide | ACTIVE MOIETY | SOI2LOH54Z | 3 | |
| acacia | INACTIVE INGREDIENT | 5C5403N26O | 3 | |
| ascorbyl palmitate | INACTIVE INGREDIENT | QN83US2B0N | 3 | |
| Calcium Phosphate, Dibasic, Anhydrous | INACTIVE INGREDIENT | L11K75P92J | 3 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 3 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 3 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | 3 | |
| FD&C blue No. 2 | INACTIVE INGREDIENT | L06K8R7DQK | 3 | |
| FD&C yellow No. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 3 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 3 | |
| polyvinyl alcohol | INACTIVE INGREDIENT | 532B59J990 | 3 | |
| potassium citrate anhydrous | INACTIVE INGREDIENT | 86R1NVR0HW | 3 | |
| povidone K30 | INACTIVE INGREDIENT | U725QWY32X | 3 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 3 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 3 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 13811-519 | 13811-519-01, 13811-519-10, 13811-519-50 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| acacia | ACACIA | 5C5403N26O | CAPSULE / ORAL | 20 mg | ||
| Calcium Phosphate, Dibasic, Anhydrous | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | PASTILLE / ORAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | POWDER, FOR SUSPENSION / ORAL | 257 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| talc | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TABLET / SUBLINGUAL | 30 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | INJECTION / INTRAMUSCULAR | 1 %w/v | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TABLET / ORAL | 2828 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TABLET, CHEWABLE / ORAL | 245 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| ascorbyl palmitate | ASCORBYL PALMITATE | QN83US2B0N | TABLET / ORAL | 7.14 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| Calcium Phosphate, Dibasic, Anhydrous | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET, COATED / ORAL | 333.3 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | AEROSOL, FOAM / TOPICAL | 1.9 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TABLET / BUCCAL | 1 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| acacia | ACACIA | 5C5403N26O | TABLET, DELAYED RELEASE / ORAL | 30 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| povidone K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| acacia | ACACIA | 5C5403N26O | POWDER, FOR SOLUTION / ORAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| FD&C blue No. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, CHEWABLE / ORAL | 3 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| talc | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| Calcium Phosphate, Dibasic, Anhydrous | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | TABLET / ORAL | 2240 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Folic Acid | FOLIC ACID | REMEDYREPACK INC. | bda4687e-929a-434d-ab59-909cf2ed73a2 | 2026-09-11 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | REMEDYREPACK INC. | 368b69a8-a021-47e3-a6d7-e3497d7363b1 | 2026-09-04 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Rising Pharma Holdings, Inc. | 0baa10dd-6d1d-4946-8236-566451132da3 | 2026-07-24 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Northwind Health Company, LLC | 03b0aee4-804a-de63-e063-6394a90a6635 | 2026-07-13 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Unit Dose Solutions, Inc. | 54db8b21-87b9-5e0c-e063-6394a90ae8ea | 2026-06-22 | Warnings, Adverse reactions | FOLIC ACID |
| Vitramyn | FOLIC ACID | PureTek Corporation | c8af7616-5178-6df0-e053-2a95a90a334d | 2026-06-18 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Coupler LLC | 544e394d-3555-8ab1-e063-6394a90ade00 | 2026-06-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Major Pharmaceuticals | 7778ac96-7817-455a-a177-22ecb276c67f | 2026-05-26 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | QUAGEN PHARMACEUTICALS LLC | 354366ea-3702-4706-9fc0-0244b7278bd8 | 2026-05-20 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 624469a1-ded9-453a-973e-c5a2f0602bb0 | 2026-05-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 6dd867fe-597e-4915-8baf-98a605bf9324 | 2026-05-06 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | a1b71c5d-c842-43fd-9557-2bb4e934b914 | 2026-04-23 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Preferred Pharmaceuticals Inc. | b4c3a754-64cd-499a-a32f-a6e935c41355 | 2026-04-22 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Amneal Pharmaceuticals of New York LLC | fd85395e-6a0b-4072-a80b-36095c0c6dd6 | 2026-04-15 | Warnings, Adverse reactions | FOLIC ACID |
| Multitam | FOLIC ACID | PureTek Corporation | cee15842-4a9e-c6ba-e053-2a95a90aebc5 | 2026-04-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | XGen Pharmaceuticals DJB, Inc. | c5b2b84d-9f5e-4b81-ba10-9f2854e5dce9 | 2026-01-21 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Aphena Pharma Solutions - Tennessee, LLC | 40ab3c91-5a5b-fa1d-e063-6394a90a7454 | 2025-12-10 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | American Health Packaging | fc6dc1e1-f63e-4239-a1eb-67525569f68c | 2025-11-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 4889d474-bd72-46ba-81d6-5511d8a85abb | 2025-11-04 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 41914ac8-f4f5-4d70-b9f2-9f88c59d67a6 | 2025-10-29 | Warnings, Adverse reactions | FOLIC ACID |
Adverse event summaries are temporarily unavailable. Other product information remains available.